SCHEMBL3633752

SCHEMBL3633752

O=Cc1cccc(SCc2ccccc2)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
ERN1 O75460 4/20 0.46
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 2/20 0.42
THRB P10828 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
LMNA P02545 1/20 0.42
BLM P54132 1/20 0.42
PTPRC P08575 1/20 0.42
TLR2 O60603 1/20 0.40
TLR1 Q15399 1/20 0.40
TLR6 Q9Y2C9 1/20 0.40
TRIM24 O15164 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
HTT P42858 1/20 0.39
DAO P14920 3/20 0.39
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3181540 0.84 POLB (0.55) POLBKMT2AL3MBTL1MEN1THRB
SCHEMBL26507173 0.81 POLB (0.47) POLBERN1KMT2AL3MBTL1MEN1
SCHEMBL983464 0.78 ERN1 (0.52) ERN1KMT2AMEN1THRBTDP1
SCHEMBL8965738 0.77 TRIM24 (0.48) POLBERN1KMT2AMEN1THRB
SCHEMBL13035643 0.77 TEAD3 (0.39) ERN1L3MBTL1TDP1TLR2TLR1
SCHEMBL31444049 0.76 KMT2A (0.55) POLBKMT2AL3MBTL1MEN1TDP1
SCHEMBL4423140 0.76 ERN1 (0.52) ERN1KMT2AMEN1THRBTDP1
SCHEMBL13073928 0.74 ERN1 (0.46) POLBERN1KMT2AL3MBTL1MEN1
SCHEMBL13035637 0.74 ERN1 (0.46) ERN1KMT2AMEN1THRBTDP1
SCHEMBL22647143 0.74 POLB (0.50) POLBKMT2AL3MBTL1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
EP-2155703-A1 BICYCLOSULFONYL ACID (BCSA) COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Inhibox Ltd. (GB) 2010-02-24 EP disclosed
WO-2008142376-A1 BICYCLOSULFONYL ACID (BCSA) COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS INHIBOX LTD. (GB) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents TNF, CS, COASY POLB 898/4885ERN1 2964/4885KMT2A 3075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.